HK Stock MarketDetailed Quotes
00950 LEE'S PHARM
- 1.190
- 0.0000.00%
Market Closed Sep 27 16:08 CST
700.71MMarket Cap11.12P/E (TTM)
1.240High1.160Low128.50KVolume1.180Open1.190Pre Close152.68KTurnover0.02%Turnover Ratio42.50P/E (Static)588.84MShares1.72052wk High0.41P/B700.71MFloat Cap0.97052wk Low0.03Dividend TTM588.84MShs Float14.729Historical High0.018Dividend LFY6.72%Amplitude-0.869Historical Low1.188Avg Price500Lot Size2.52%Div YieldTTM1.51%Div Yield LFY
LEE'S PHARM Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 28.51%658.35M | -14.61%1.05B | -21.08%512.31M | -2.61%1.23B | 8.80%1.04B | 11.15%649.17M | 14.70%324.75M | 4.06%1.27B | 6.53%952.39M | 4.91%584.05M |
| Operating income | 28.51%658.35M | -14.61%1.05B | -21.08%512.31M | -2.61%1.23B | 8.80%1.04B | 11.15%649.17M | 14.70%324.75M | 4.06%1.27B | 6.53%952.39M | 4.91%584.05M |
| Cost of sales | -35.07%-307.75M | -8.51%-501.72M | 0.80%-227.85M | -0.55%-462.39M | -17.88%-374.38M | -16.29%-229.69M | -20.05%-108.92M | -5.56%-459.87M | 0.25%-317.59M | -3.35%-197.51M |
| Operating expenses | -35.07%-307.75M | -8.51%-501.72M | 0.80%-227.85M | -0.55%-462.39M | -17.88%-374.38M | -16.29%-229.69M | -20.05%-108.92M | -5.56%-459.87M | 0.25%-317.59M | -3.35%-197.51M |
| Gross profit | 23.25%350.6M | -28.47%551.31M | -32.19%284.46M | -4.41%770.76M | 4.25%661.8M | 8.52%419.48M | 12.17%215.83M | 3.23%806.28M | 10.27%634.8M | 5.72%386.55M |
| Selling expenses | -17.24%-172.27M | 12.17%-304.3M | 16.62%-146.93M | 5.45%-346.47M | -3.96%-269.12M | -7.37%-176.22M | -12.95%-81.97M | -30.90%-366.44M | -35.97%-258.86M | -34.37%-164.12M |
| Administrative expenses | -7.14%-97.05M | 4.94%-188.61M | 18.45%-90.58M | 33.25%-198.41M | 21.71%-169.33M | 10.57%-111.08M | 2.70%-57.28M | -25.05%-297.27M | -22.10%-216.28M | -11.76%-124.2M |
| Research and development expenses | 30.17%-34.08M | 42.68%-96.8M | 58.15%-48.8M | 30.74%-168.89M | 7.53%-166.85M | -3.27%-116.59M | -28.77%-61.63M | -19.94%-243.84M | -26.12%-180.45M | -50.21%-112.9M |
| Impairment and provision | 33.11%-198K | -586.69%-1.28M | -17.00%-296K | 100.29%263K | -1,196.65%-1.96M | 39.62%-253K | -1,367.88%-4.18M | -7,551.19%-90.28M | 166.54%179K | 28.62%-419K |
| -Other impairment is provision | 33.11%-198K | -586.69%-1.28M | -17.00%-296K | 100.29%263K | -1,196.65%-1.96M | 39.62%-253K | -1,367.88%-4.18M | -7,551.19%-90.28M | 166.54%179K | 28.62%-419K |
| Special items of operating profit | -39.99%21.13M | 331.11%83.23M | -13.00%35.21M | -99.11%19.31M | -97.45%55.55M | -98.12%40.48M | -27.09%24.74M | 2,233.49%2.17B | 2,995.46%2.18B | 3,605.77%2.16B |
| Operating profit | 106.05%68.13M | -43.11%43.55M | -40.76%33.07M | -96.13%76.56M | -94.89%110.09M | -97.40%55.82M | -25.05%35.5M | 1,202.36%1.98B | 1,495.08%2.15B | 1,766.14%2.14B |
| Financing cost | -24.78%-6.79M | -56.66%-11.9M | -55.44%-5.44M | -32.73%-7.6M | -23.81%-5.29M | -38.68%-3.5M | -36.66%-1.74M | 11.59%-5.72M | 16.04%-4.28M | 28.83%-2.52M |
| Share of profits of associates | 45.68%-239K | 21.20%-870K | 16.35%-440K | 68.41%-1.1M | 77.68%-753K | 84.11%-526K | 88.74%-255K | 69.38%-3.5M | 57.85%-3.37M | 45.17%-3.31M |
| Earning before tax | 124.76%61.11M | -54.64%30.79M | -47.51%27.19M | -96.55%67.86M | -95.15%104.04M | -97.58%51.8M | -23.54%33.51M | 1,369.27%1.97B | 1,660.01%2.15B | 1,930.51%2.14B |
| Tax | 0.64%-6.24M | 50.80%-10.84M | 74.59%-6.28M | -132.29%-22.03M | -1,841.05%-45.34M | -631.80%-24.71M | -71.85%-12.85M | 82.92%-9.48M | 94.48%-2.34M | 88.48%-3.38M |
| After-tax profit from continuing operations | 162.42%54.87M | -56.48%19.95M | -22.79%20.91M | -97.66%45.84M | -97.26%58.7M | -98.73%27.08M | -43.16%20.67M | 2,395.59%1.96B | 2,591.66%2.14B | 2,709.95%2.13B |
| Earning after tax | 162.42%54.87M | -56.48%19.95M | -22.79%20.91M | -97.66%45.84M | -97.26%58.7M | -98.73%27.08M | -43.16%20.67M | 2,395.59%1.96B | 2,591.66%2.14B | 2,709.95%2.13B |
| Minority profit | -258.79%-7.61M | 159.66%3.25M | 447.75%4.79M | 80.03%-5.45M | 83.43%-3.99M | 93.53%-1.38M | 107.63%358K | 46.26%-27.29M | 43.15%-24.06M | -1.22%-21.3M |
| Profit attributable to shareholders | 287.65%62.48M | -67.44%16.7M | -43.37%16.12M | -97.42%51.28M | -97.11%62.68M | -98.68%28.46M | -50.53%20.31M | 1,436.68%1.99B | 1,677.82%2.17B | 2,122.27%2.16B |
| Basic earnings per share | 287.23%0.1061 | -67.39%0.0284 | -43.27%0.0274 | -97.42%0.0871 | -97.11%0.1065 | -98.68%0.0483 | -50.57%0.0345 | 1,435.15%3.3758 | 1,676.00%3.6852 | 2,120.98%3.6624 |
| Diluted earnings per share | 287.23%0.1061 | -67.39%0.0284 | -43.27%0.0274 | -97.42%0.0871 | -97.11%0.1065 | -98.68%0.0483 | -50.50%0.0345 | 1,434.11%3.3735 | 1,675.99%3.6834 | 2,119.53%3.66 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Hengjian Certified Public Accountants Limited | -- | -- | -- | Hengjian Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data